121 related articles for article (PubMed ID: 24126978)
1. Lentivirus-mediated inhibition of USP39 suppresses the growth of breast cancer cells in vitro.
Wang H; Ji X; Liu X; Yao R; Chi J; Liu S; Wang Y; Cao W; Zhou Q
Oncol Rep; 2013 Dec; 30(6):2871-7. PubMed ID: 24126978
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral vector-mediated doxycycline-inducible USP39 shRNA or cDNA expression in triple-negative breast cancer cells.
Liu S; Liu X; Wang H; Zhou Q; Liang Y; Sui A; Yao R; Zhao B; Sun M
Oncol Rep; 2015 May; 33(5):2477-83. PubMed ID: 25812575
[TBL] [Abstract][Full Text] [Related]
3. Lentivirus-mediated inhibition of USP39 suppresses the growth of gastric cancer cells via PARP activation.
Wang X; Yu Q; Huang L; Yu P
Mol Med Rep; 2016 Jul; 14(1):301-6. PubMed ID: 27175747
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma.
Zhao Y; Zhang B; Lei Y; Sun J; Zhang Y; Yang S; Zhang X
Tumour Biol; 2016 Oct; 37(10):13167-13176. PubMed ID: 27456357
[TBL] [Abstract][Full Text] [Related]
5. Lentivirus mediated silencing of ubiquitin specific peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro.
Pan Z; Pan H; Zhang J; Yang Y; Liu H; Yang Y; Huang G; Ni J; Huang J; Zhou W
Biol Res; 2015 Mar; 48(1):18. PubMed ID: 25889525
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of USP39 by lentivirus-mediated RNA interference suppresses the growth of oral squamous cell carcinoma.
Li KY; Zhang J; Jiang LC; Zhang B; Xia CP; Xu K; Chen HY; Yang QZ; Liu SW; Zhu H
Cancer Biomark; 2016; 16(1):137-144. PubMed ID: 26835714
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of ubiquitin-specific peptidase 39 inhibited the growth of osteosarcoma cells and induced apoptosis in vitro.
Gan Z; Han K; Lin S; Hu H; Shen Z; Min D
Biol Res; 2017 Apr; 50(1):15. PubMed ID: 28403900
[TBL] [Abstract][Full Text] [Related]
8. USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo.
Yuan X; Sun X; Shi X; Jiang C; Yu D; Zhang W; Guan W; Zhou J; Wu Y; Qiu Y; Ding Y
Oncol Rep; 2015 Aug; 34(2):823-32. PubMed ID: 26081192
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-specific protease 39 is overexpressed in human lung cancer and promotes tumor cell proliferation in vitro.
Lin Z; Xiong L; Lin Q
Mol Cell Biochem; 2016 Nov; 422(1-2):97-107. PubMed ID: 27629785
[TBL] [Abstract][Full Text] [Related]
10. USP39 regulates the cell cycle, survival, and growth of human leukemia cells.
Liu C; Yao X; Li M; Xi Y; Zhao L
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898977
[TBL] [Abstract][Full Text] [Related]
11. USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway.
Cai J; Liu T; Huang P; Yan W; Guo C; Xiong L; Liu A
Biochem Biophys Res Commun; 2017 Apr; 486(1):184-190. PubMed ID: 28286270
[TBL] [Abstract][Full Text] [Related]
12. Knocking down USP39 Inhibits the Growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway.
Yuan J; Zhang G; Li X; Ma Q; Cheng W; Wang W; Zhang B; Hu T; Song G
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255748
[TBL] [Abstract][Full Text] [Related]
13. Effects of RNA interference-mediated NRP-1 silencing on the proliferation and apoptosis of breast cancer cells.
Han Z; Jiang G; Zhang Y; Xu J; Chen C; Zhang L; Xu Z; Du X
Mol Med Rep; 2015 Jul; 12(1):513-9. PubMed ID: 25738638
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation.
Huang Y; Pan XW; Li L; Chen L; Liu X; Lu JL; Zhu XM; Huang H; Yang QW; Ye JQ; Gan SS; Wang LH; Hong Y; Xu DF; Cui XG
Oncotarget; 2016 Apr; 7(16):22016-30. PubMed ID: 26959883
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of ubiquitin‑specific peptidase 39 inhibits the malignant progression of human renal cell carcinoma.
Xu Y; Zhu MR; Zhang JY; Si GM; Lv JJ
Mol Med Rep; 2018 Mar; 17(3):4729-4735. PubMed ID: 29328477
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated downregulation of cyclin Y to attenuate human breast cancer cell growth.
Yan F; Wang X; Zhu M; Hu X
Oncol Rep; 2016 Nov; 36(5):2793-2799. PubMed ID: 27666310
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of ubiquitin-specific peptidase 39 suppresses the proliferation and induces the apoptosis of human colorectal cancer cells.
Xing Z; Sun F; He W; Wang Z; Song X; Zhang F
Oncol Lett; 2018 Apr; 15(4):5443-5450. PubMed ID: 29556295
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of human intercellular adhesion molecule-1 attenuates the metastatic ability in human breast cancer cell lines.
Di D; Chen L; Wang L; Sun P; Liu Y; Xu Z; Ju J
Oncol Rep; 2016 Mar; 35(3):1541-8. PubMed ID: 26751847
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle.
Yang M; Gao H; Chen P; Jia J; Wu S
Oncol Rep; 2013 Jul; 30(1):171-8. PubMed ID: 23624618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
